Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vascular Surgery

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 13 articles: HTML format

Single Articles

February 2025
1. ZHENG YY, Wu TT, Hou XG, Yang Y, et al
   Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study.
   Thromb Haemost. 2025;125:178-187.
   PubMed     Abstract available
   
   
   January 2025
2. XIANG Y, Zhang P, Lai Y, Wang D, et al
   Risk Factors, Antithrombotic Management, and Long-Term Outcomes of Patients Undergoing Endovascular Treatment of Unruptured Intracranial Aneurysms.
   Thromb Haemost. 2025;125:58-68.
   PubMed     Abstract available
   
   
   September 2024
3. MUSIALEK P, Rosenfield K, Siddiqui AH, Grunwald IQ, et al
   Carotid Stenosis and Stroke: Medicines, Stents, Surgery-"Wait-and-See" or Protect?
   Thromb Haemost. 2024;124:815-827.
   PubMed    
   
   
   June 2024
4. CATTANEO M, Squizzato A, Birocchi S, Podda GM, et al
   Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention.
   Thromb Haemost. 2024;124:595-597.
   PubMed    
   
   
   
5. UEKI Y, Haner JD, Losdat S, Gargiulo G, et al
   Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
   Thromb Haemost. 2024;124:517-527.
   PubMed     Abstract available
   
   
   May 2024
6. LANDOLINA D, Ammirabile N, Capodanno D
   Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances.
   Thromb Haemost. 2024;124:497-499.
   PubMed    
   
   
   
7. BIROCCHI S, Rocchetti M, Minardi A, Podda GM, et al
   Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design.
   Thromb Haemost. 2024;124:482-496.
   PubMed     Abstract available
   
   
   March 2024
8. ORTEGA-PAZ L, Franchi F, Rollini F, Galli M, et al
   Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
   Thromb Haemost. 2024;124:263-273.
   PubMed     Abstract available
   
   
   December 2023
9. YE Y, Hao Y, Zhao X, Liu J, et al
   Percutaneous coronary intervention in acute coronary syndrome with mild-to-moderate thrombocytopenia.
   Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5263.
   PubMed     Abstract available
   
   
   October 2023
10. PEDERSEN OB, Hvas AM, Pasalic L, Kristensen SD, et al
    Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction.
    Thromb Haemost. 2023 Oct 16. doi: 10.1055/s-0043-1776305.
    PubMed     Abstract available
    
    
    September 2023
11. BONGIOVANNI D, Novelli L, Condello F, Kirmes K, et al
    Reticulated Platelets Predict Cardiovascular Death and Adverse Events in Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2023 Sep 11. doi: 10.1055/s-0043-1773763.
    PubMed     Abstract available
    
    
    August 2023
12. HE HM, Chen YN, Zeng JL, Zheng SW, et al
    The Prognostic Value of the Age-D-Dimer-Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 29. doi: 10.1055/s-0043-1773764.
    PubMed     Abstract available
    
    
    
13. LAHU S, Adler K, Mayer K, Hein-Rothweiler R, et al
    Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 17. doi: 10.1055/s-0043-1772221.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge.